Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

KM109_Human oligo batch II

ABSTRACT: Timecourse experiment hybridized to human oligo array part II. Healthy human primary myoblasts (KM109). Keywords: time-course

ORGANISM(S): Homo sapiens

PROVIDER: GSE909 | GEO | 2004/02/12

SECONDARY ACCESSION(S): PRJNA87927

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

KM109_Human oligo batch I

Project description:Timecourse experiment of healthy human primary myoblast cells (KM109) Keywords: time-course

2004-02-12 | GSE908 | GEO

Whole Human Genome Oligo Microarray

Project description:Human expression microarray analysis of the 11 samples that you submitted. Total RNA from each sample was quantified using the NanoDrop ND-1000 and the RNA integrity was assessed using standard denaturing agarose gel electrophoresis. For microarray analysis, Agilent Array platform was employed. The sample preparation and microarray hybridization were performed according to the manufacturer’s standard protocols. Briefly, total RNA from each sample was amplified and transcribed into fluorescent cRNA with using the manufacturer’s Agilent’s Quick Amp Labeling protocol (version 5.7, Agilent Technologies). The labeled cRNAs were hybridized onto the Whole Human Genome Oligo Microarray (4x44K, Agilent Technologies). After having washed the slides, the arrays were scanned by the Agilent Scanner G2505C. Agilent Feature Extraction software (version 11.0.1.1) was used to analyze acquired array images. Quantile normalization and subsequent data processing were performed using the GeneSpring GX v11.5 software package (Agilent Technologies). After quantile normalization of the raw data, genes that at least 7 out of 11 samples have flags in Detected (“All Targets Value”) were chosen for further data analysis.

2017-03-02 | GSE95563 | GEO

GENCODE PCR-Seq Batch II

Project description:As part of the ENCODE consortium the GENCODE project is producing a reference gene set through manual and automated gene prediction. Selected transcript models are verified experimentally by RT-PCR amplification followed by sequencing. This is batch II, based on annotation from April 2009.

2010-11-01 | E-MTAB-407 | biostudies-arrayexpress

KM108_cDNA

Project description:Timecourse experiment of healthy human primary skeletal muscle cells (KM108) Keywords: time-course

2004-02-12 | GSE895 | GEO

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Project description:This is a phase 2 pragmatic study that evaluates the clinical benefit of continuing systemic therapy with the addition of locally ablative therapies for oligo-progressive solid tumors as the primary objective. The primary outcome measure is the time to treatment failure (defined as time to change in systemic failure or permanent discontinuation of therapy) following locally ablative therapy.

| 114756 | ecrin-mdr-crc

Identifying novel surface markers for megakaryocyte progenitor cells [timecourse transgene]

Project description:We carried out 10X sequencing of a timecourse of human induced pluripotent stem cells over a course of 20 days as they differentiated towards megakaryocytes.

2022-02-23 | GSE166723 | GEO

Identifying novel surface markers for megakaryocyte progenitor cells [10x timecourse]

Project description:We carried out 10X sequencing of a timecourse of human induced pluripotent stem cells over a course of 20 days as they differentiated towards megakaryocytes.

2022-02-23 | GSE160604 | GEO

Analysis of transcripts in PNA-A(15) oligo treated human HEK-293 cells

Project description:Mononucleotide A and T repeats are abundant in human genome. Many of A repeats are bound by Argonaute proteins (AGOs). To evaluate the role of AGOs and A repeats in gene regulation, HEK293 cells were treated with 8-amino-3,6-dioxaoctanoic acid added peptide nucleic acid (PNA) AAAAAAAAAAAAAAA oligo (OO-A(15)). Matched two sets of two individual HEK293 cells were transfected with OO-A(15) and scramble OO-PNA oligo, and were analyzed as biological duplicates. Cells were grown in DMEM (Gibco-BRL) according to the manufacturer’s protocol. OO-A(15) and scramble oligo were dilute with dH2O to reach 10μM. Cells were transfected in 6-well plates, seed 6 x 105 cells per well with 50 nM OO-A(15) and scramble oligo using TransIT-siQUEST transfection reagent (Mirus). The transfected cell lines were cultured for 48 h post-transfection and harvested total RNA by Trizol reagent (Invitrogen). All RNA integrity assays were performed and hybridized on beadchip according to the protocol.

2013-09-03 | E-GEOD-43185 | biostudies-arrayexpress

Spo11-oligo mapping in S. cerevisiae strain SK1

Project description:Spo11-oligo mapping in S. cerevisiae strain SK1

2020-07-23 | GSE152957 | GEO

NCI60 Expression Profiling using the Agilent Whole Human Genome Oligo Microarray

Project description:We present here a new expression profiling study of the 60 cell lines of the National Cancer Institute (NCI) Developmental Therapeutics program (DTP) drug screen (NCI-60) using the 41,000-probe Agilent Whole Human Genome Oligo Microarray. The expression levels of ∼21,000 genes were measured.

2010-08-01 | GSE22821 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data